Lv6
2180 积分 2024-12-24 加入
Efficacy and Safety of Pharmacological Interventions in Managing Cardiometabolic Risk Factors in Youth Living with Overweight and Obesity: A Systematic Review and Network Meta‐Analysis
18天前
已完结
A machine learning model using echocardiographic myocardial strain to detect myocardial ischemia
1个月前
已关闭
Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor co-agonists for cardioprotection, type 2 diabetes and obesity: a review of mechanisms and clinical data
1个月前
已完结
Glucagon and energy expenditure; Revisiting amino acid metabolism and implications for weight loss therapy
1个月前
已完结
Deliberating the striking effect of dual GLP-1R and GIPR agonists on “Diabesity” in light of precision medicine and pharmacogenomics
1个月前
已完结
Next Generation Dual GLP-1/GIP, GLP-1/Glucagon, and Triple GLP-1/GIP/Glucagon Agonists: A Literature Review
1个月前
已完结
Transforming obesity: The advancement of multi-receptor drugs
1个月前
已完结
Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss
1个月前
已完结
GIP Receptor Antagonists in the Pharmacotherapy of Obesity: Physiologic, Genetic, and Clinical Rationale
1个月前
已完结
Effects on glucose homeostasis and insulin secretion of long term activation of the glucose-dependent insulinotropic polypeptide (GIP) receptor by N-AcGIP(LysPAL37) in normal mice
1个月前
已完结
皖公网安备34019202002308
